PRUMOTILITY 1 TAB is a specialized gastrointestinal prokinetic formulation containing Prucalopride Succinate, equivalent to 1 mg of Prucalopride. This advanced therapeutic agent is specifically indicated for the management of chronic idiopathic constipation (CIC) in adults, particularly in those who have not achieved satisfactory relief with conventional laxatives or fiber supplementation. The formulation is designed and manufactured by Bluepill Express, adhering to global GMP, ISO, and WHO-compliant protocols.

Prucalopride is a highly selective serotonin (5-HT4) receptor agonist. It acts by stimulating enteric neurons, thereby promoting coordinated peristaltic contractions and enhancing colonic transit. Unlike older generation prokinetic drugs, Prucalopride exhibits minimal cardiovascular risk due to its receptor selectivity and favorable safety profile, making it a preferred long-term treatment option in gastrointestinal motility disorders.

PRUMOTILITY 1 TAB effectively reduces transit time, increases bowel movement frequency, and improves stool consistency. This leads to a significant reduction in straining, bloating, and abdominal discomfort in patients suffering from persistent constipation. Clinical trials have consistently shown that Prucalopride provides sustained relief and improves overall patient quality of life over continued use.

This product is especially useful in populations where constipation becomes a chronic condition, such as elderly patients, those on long-term opioid therapy, patients with sedentary lifestyles, or individuals suffering from conditions like irritable bowel syndrome with constipation (IBS-C). Although the main indication is chronic idiopathic constipation, it may also find off-label utility in other forms of functional gastrointestinal hypomotility, as prescribed by specialists.

PRUMOTILITY 1 TAB is formulated for once-daily oral administration, ideally taken at the same time each day, with or without food. The onset of therapeutic effect typically begins within a few days of initiation and continues to improve with consistent use. It is generally well tolerated, with side effects being mild and transient in most cases. Some patients may report headache, abdominal pain, nausea, or diarrhea during the first few days of therapy, but these usually subside.

As a third-party manufacturing partner, Bluepill Express ensures that every batch of PRUMOTILITY 1 TAB undergoes extensive quality assurance processes. These include uniformity of content, dissolution testing, impurity profiling, and stability testing under ICH conditions. We offer comprehensive regulatory documentation support, including DMF access, COAs, stability data, method validation reports, and international shipping documentation for easy global market registration.

Our world-class manufacturing units support high-volume production while maintaining strict controls over cross-contamination, microbial limits, and packaging integrity. PRUMOTILITY 1 TAB is available in blister packs and alu-alu formats, with customizable branding and labeling options for private label distribution.

As a key exporter of gastrointestinal and prokinetic drugs, Bluepill Express distributes to over 140 countries, serving pharmaceutical importers, hospitals, and governments across Latin America, Africa, the Middle East, Europe, and Southeast Asia. We understand the critical importance of maintaining consistent therapeutic efficacy and safety standards, especially for patients relying on long-term treatment for chronic bowel disorders.